Accounting for unobservable exposure time bias when using Medicare prescription drug data
Accounting for unobservable exposure time bias when using Medicare prescription drug data
About this item
Full title
Author / Creator
Publisher
United States: Centers for Medicare & Medicaid Services
Journal title
Language
English
Formats
Publication information
Publisher
United States: Centers for Medicare & Medicaid Services
Subjects
More information
Scope and Contents
Contents
To describe the prevalence and correlates of unobservable medication exposure time, and to recommend approaches for minimizing bias, in studies using Medicare Part D data..
179,065 Medicare patients hospitalized for an AMI in 2007 or 2008.
We compared two methods for creating medication exposure observation periods using acute care discharge...
Alternative Titles
Full title
Accounting for unobservable exposure time bias when using Medicare prescription drug data
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4011646
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4011646
Other Identifiers
ISSN
2159-0354
E-ISSN
2159-0354
DOI
10.5600/mmrr.003.04.a01
